Chagas disease predicts 10-year stroke mortality in community-dwelling elderly: The bambuí cohort study of aging

Stroke

Volumn 41, Issue 11, 2010, Pages 2477-2482

  Lima Costa, Maria Fernanda ^a,b   Matos, Divane L ^a   Ribeiro, Antônio Luiz P ^b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

brain natriuretic peptide; Chagas disease; epidemiology; etiology; prognosis; risk factors; stroke mortality; Trypanosoma cruzi

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CHAGAS DISEASE; CHRONIC DISEASE; COHORT ANALYSIS; COMMUNITY LIVING; CONFOUNDING VARIABLE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; FEMALE; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SMOKING; STROKE; SYSTOLIC BLOOD PRESSURE; TRYPANOSOMA CRUZI;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BRAZIL; C-REACTIVE PROTEIN; CHAGAS DISEASE; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; SURVIVAL RATE; TRYPANOSOMA CRUZI;

EID: 78149333893     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.588061     Document Type: Article

References (28)

1. World Health Organization: Report sobre La enfermedad de Chagas. Buenos Aires, Pan American Health Organization/World Health Organization 2007. Available at: www.who.int/tdr. Accessed April 17, 2008.
2. Gascon J, Bern C, Pinazo MJ. Chagas disease in Spain, the United States and other non-endemic countries. Acta Trop. 2010;115:22-27.
3. Carod-Artal FJ, Gascon J. Chagas disease and stroke. Lancet Neurol. 2010;9:533-542.
4. Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis. 2001;1:92-100.
5. Kierszenbaum F. Where do we stand on the autoimmunity hypothesis of Chagas disease? Trends Parasitol. 2005;21:513-516.
6. Petkova SB, Huang H, Factor SM, Pestell RG, Bouzahzah B, Jelicks LA, Weiss LM, Crist GJ, Lisanti MP, Doutglas SA, Shturin V, Halonen SK, Wittner M, Tanowitz HB. The role of endothelin in the pathogenesis of Chagas'disease. Int J Parasitol. 2001;31:499-511.
7. Leon-Sarmiento FE, Mendonza E, Torres-Hillera M, Pinto N, Prada AJ, Silva CA, Vera CSJ, Castilo E, Valderrama V, Prada DG, Bayona Priet J, Garcia I. Trypanosoma cruzi-associated cerebrovascular disease: a case-control study in Eastern Colombia. J Neurol Sci. 2004;217:61-64.
8. Oliveira Filho J, Viana LC, Vieira de Melo RM. Faiçal F, Torreão JA, Villar FAGA, Reis FJFB. Chagas disease is an independent risk factor for stroke: baseline characteristics of a Chagas disease cohort. Stroke. 2005; 36:2015-2017.
9. Paixão LC, Ribeiro AL, Valacio RA, Teixeira AL. Chagas disease: independent risk factor for stroke. Stroke. 2009;40:3691-3694.
10. Lindsberg PJ, Grau AJ. Inflammation and infections as risk factors for ischemic stroke. Stroke. 2003;34:2518-2532.
11. Bestetti R. Stroke in a hospital-derived cohort of patients with chronic Chagas ' disease. Acta Cardiol. 2000;55:33-38.
12. Sousa AS, Xavier SS, Freitas GR, Hasslocher-Moreno A. Prevention strategies of cardioembolic ischemic stroke in Chagas ' disease. Arq Bras Cardiol. 2008;91:306-310.
13. Nunes MCP, Barbosa MM, Ribeiro ALP, Barbosa FBL, Rocha MOC. Ischemic cerebrovascular events in patients with Chagas cardiomyopathy: a prospective follow-up study. J Neurol Sci. 2009;278:96-101.
14. Di Angelantonio E, Chowdhury R, Sarwar N, Ray KK, Gobin R, Saleheen D, Thompson A, Gudnason V, Sattar N, Danesh J. B-type natriuretic peptides and cardiovascular risk. Systematic review and meta-analysis of 40 prospective studies. Circulation. 2009;120: 2177-2187.
15. Ribeiro AL, Teixeira MM, Reis AM, Talvani A, Perez AA, Barros MV, Rocha MO. Brain natriuretic peptide based strategy to detect left ventricular dysfunction in Chagas disease: a comparison with the conventional approach. Int J Cardiol. 2006;109:34-40.
16. Lima-Costa MF, Cesar CC, Peixoto SV, Ribeiro ALP. Plasma B-type natriuretic peptide as a predictor of mortality in community-dwelling older adults with Chagas disease: 10-year follow-up of the Bambuí Cohort Study. Am J Epidemiol. 2010;172:190-196.
17. Pinto Dias JC. Natural history of Chagas disease. Arq Bras Cardiol. 1995;65:359-366.
18. Lima e Costa MFL, Barreto SM, Guerra HL, Firmo JO, Uchoa E, Vidigal PJ. Ageing with Trypanosoma cruzi infection in a community where the transmission has been interrupted: the Bambui Health and Ageing Study (BHAS). Int J Epidemiol. 2001;30:887-893.
19. Lima-Costa MF, Firmo JOA, Uchoa E. Cohort profile: the Bambuí (Brazil) cohort study of ageing. Int J Epidemiol [Epub ahead of print August 30, 2010].
20. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings. Littleton, MA: John Wright-PSG; 1982.
21. Maguirre JH, Hoff R, Sherlock I, Guimaraes AC, Sleight AD, Ramos NR, Mott KE, Weller TH. Cardiac morbidity and mortality due to Chagas ' disease: prospective electrocardiographic study of a Brazilian community. Circulation. 1987;75:1140-1145.
22. D'Agostino RB, Wolf PA, Belanger AJ, Kannel WB. Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study. Stroke. 1004;25:40-43.
23. Bineau S, Dufouil C, Helmer C, Ritchie K, Empana Jean-Philippe, Duci-metiere P, Alperovitch A, Bousser MG, Tzourio C. Framingham stroke risk function in a large population-based cohort of elderly people: the 3C study. Stroke. 2009;40:1564-1570.
24. Bern C, Montgomery SP, Herwaldt BL, Rassi A Jr, Marin-Neto JA, Dantas RO, Maguire JH, Acquatella H, Morillo C, Kirchhoff LV, Gilman RH, Reyes PA, Salvatella R, Moore AC. Evaluation and treatment of chagas disease in the United States: a systematic review. JAMA. 2007; 298:2171-2181.
25. Carod-Artal FJ, Vargas AP, Horan RA, Nunes LGN. Chagasic cardiomyopathy is independently associated with ischemic stroke in Chagas disease. Stroke. 2005;36:965-970.
26. Pullicino P, Homma S. Stroke in heart failure: atrial fibrillation revised? Stroke Cerebrovasc Dis. 2010;19:1-2.
27. Lima-Costa MF, Matos DL, Laurenti R, Mello Jorge MH, Cesar CC. Time trends and predictors of 9-year ill defined cause of death in Brazilian older adults: the Bambui Cohort Study. Cadernos de Saude Publica [Reports in Public Health]. 2010;26:514-522.
28. Bradford Hill A. The environment and disease: association or causation. Proc R Soc Med. 1965;58:295-300.